Saturday, May 18, 2024
Home > Stock (Page 49)

MRNA Stock Up 14% in Pre-Market as Moderna COVID-19 Vaccine Hits 94.5% Efficacy

The Moderna vaccine trial involved about 30,000 participants and the interim analysis for the vaccine was based on 95 infections among the trial participantsThe stock of an American biotechnology company that focuses on drug discovery, and drug development Moderna Inc (NASDAQ: MRNA) is soaring in today’s pre-market following reports that

Read More